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Introduction 
The central nervous system and the immune sys- 
tem are closely interrelated. Stress and psychi- 
atric illness have previously been associated with 
immune dysregulation (Calabrese et al. 1987). 
We reported earlier that patients with major 
depression manifested a reduction in mitogen- 
induced lymphocyte proliferation, a correlate of 
cellular immune function (Kronfol et al. 1983). 
These findings were later confirmed by other 
investigators (Schleifer et al. 1984). We now 
report our preliminary results on Natural-Killer 
(NK) cell activity, a more specific parameter of 
immune function directed against tumor- or vi- 
rus-infected cells, in 12 drug-free patients di- 
agnosed with major depressive disorder and 12 
age- and sex-matched normal controls. 
Subjects and Methods 
S&ejects 
There were 12 depressed patients, 5 men. 7 
women (mean -+ SD age 36.8 2 9.3). All pa- 
tients were evaluated at the Department of Psy- 
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chiatry of the University of Michigan Medical 
Center. Diagnosis was made independently by 
at least two psychiatrists in an unstructured in- 
terview using DSM-III criteria as well as Re- 
search Diagnostic Criteria (RDC) (Spitzer et al. 
1977). The RDC diagnosis was confirmed by a 
structured interview conducted by a trained re- 
search nurse using the Schedule for Affective 
Disorders and Schizophrenia (SADS) (Spitzer 
and Endicott 1975). At the time of the study? 
10 patients were hospitalized and 2 were am- 
bulatory. They all met DSM-III and RDC cri- 
teria for major depressive disorder and had a 
score of 2 1.5 on the 17-item Hamilton Depres- 
sion Rating Scale, HDRS (Hamilton 1960). All 
patients were also free of drugs known to in- 
terfere with immune regulation, and free of psy- 
choactive drugs for at least 2 weeks prior to 
immune evaluation. In fact, only 3 patients were 
receiving psychotropic medications (tricyclic 
antidepressants and/or neuroleptics) 2 weeks prior 
to the immunological assessment. The mean 2 
SD score on the HDRS was 19.5 + 4.8. The 
mean t SD score on the Carroll Depression 
Rating Scale (CDRS), a self-rating scale for 
depression (Carroll et al. 1981) was 29.0 -+ 
9.1. 
The normal control group consisted of 12 
healthy volunteers, 5 men, 7 women (mean i 
SD age 36.5 ? 9.1), who were age and sex 
matched with the depressed patients. They were 
recruited in response to ads on the campus of 
the University of Michigan. Each control sub- 
ject was interviewed with the SADS-Life Ver- 
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sion (SADS-L), and subjects with a history of 
psychiatric illness were excluded. Other exclu- 
sion criteria were history of medical illness or 
drugs known to affect the immune system. The 
mean HDRS score was 0.6 ? 0.9. The mean 
CDRS was 2.1 ? 2.5. 
Comparisons between the depressed patients 
and the normal controls revealed no significant 
age or sex differences between the groups. There 
were, however, highly significant differences in 
both the HDRS (t = 15.8; p < 0.00001) and 
the CDRS (t = 7.6;~ < 0.0001) scores between 
the two groups. 
Methods 
Blood samples from each patient and his/her 
age-and-sex-matched normal control were drawn 
separately in heparinized tubes on the same day 
between 8:00 and 9:00 AM. Blood was diluted 
with phosphate-buffered saline (PBS pH 7.3) 
and centrifuged at 400 g for 30 min over a cush- 
ion of Ficoll-Hypaque solution. The mononu- 
clear cell band was harvested, washed, and re- 
suspended in RPM1 1640 medium containing 25 
mM Hepes buffer supplemented with 10% heat- 
inactivated fetal calf serum (Gibco, Grand Is- 
land, NY), 80 pg/ml gentamicin (Scherring 
Corp., Kenilworth, NJ), and 300 pg of fresh 
glutamine/ml (complete medium). Mononuclear 
cells were depleted of adherentimonocytes by 
chromatography on a column of Sephadex G- 
10 beads (Pharmacia Fine Chemicals, Piscata- 
way, N. J .) equilibrated in the same medium. 
The cell recovery was >70% of the total input, 
and monocyte contamination as indicated by 
nonspecific esterase staining was ~2%. NK ac- 
tivity was then measured in a direct “Cr release 
assay as described previously (Nair and Schwartz 
1984). The human erythroleukemia cell line K562 
was used as targets for NK cells. Four different 
effectortarget (E:T) cell ratios were used: 50: 1, 
2S:l: 12.5:1, and 6.25:1. All samples were run 
in triplicate. Percent cytotoxicity * SD was then 
calculated for both patients and controls for each 
of the four different E:T cell ratios. The spon- 
taneous release for labeled K562 target cells was 
always less than 10% of the total labeling. 
Statistical Analysis 
Differences between patients and their matched 
controls were calculated for each E:T cell ratio 
using a paired t-test analysis. Differences be- 
tween patients and controls were also analyzed 
using repeated measures analysis of variance 
(ANOVA). Results were considered statistically 
significant wherever p < 0.05, two-tailed. 
Results 
Figure 1 shows mean 2 SD percent cytotoxicity 
of lymphocytes from depressed patients and their 
matched controls against K562 target cells. De- 
pressed patients had lower percent cytotoxicity 
values than their matched controls for all E:T 
cell ratios used. These differences were statis- 
tically significant at E:T cell ratio 50: I (t = 
2.97, n = 12, p < 0.02) and E:T cell ratio 25: 1 
(t = 3.1, n = 12, p < 0.02). A decreased cy- 
totoxicity was also demonstrated at the lowest 
E:T cell ratios 12.5:l (t = 1.89 n = 12 p < 
0.09) and 6.25:1 (t = 0.91 n = 12; NS), al- 
though these values were not significantly dif- 
ferent from controls. 
To assess the overall difference between the 
two groups, we then used repeated measures 
ANOVA of percent cytotoxicity between the 
groups. We found a significant group effect (F 
= 4.92; df = 1; p < 0.05), a significant dose 
effect (F = 247.31; df = 3;p < 0.0001) and 
a significant group by dose interaction (F = 
5.33; df = 3; p < 0.01). 
Discussion 
These results suggest that NK cell activity, a 
key component of the immune response. is de- 
creased in patients suffering from a major de- 
pressive episode. NK activity, like other defense 
mechanisms, can be affected by several clinical 
factors, including age, gender, nutritional sta- 
tus, diurnal variation, medical illness, and drugs. 
Patients and controls did not significantly differ 
in either age or gender distribution. Similarly, 
there were no significant differences in their re- 
spective mean body weights (73.0 t 18.5 kg 
for depressed patients, 65.3 2 10.9 kg for nor- 
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Figure 1, NK activity in depressed patients and matched normal controls. The results are expressed as mean 
& SD percent cytotoxicity of lymphocytes from I2 depressed patients and 12 matched controls. All samples 
were run in triplicate for each of four different ET cell ratios. The difference between the two groups was 
statistically significant (p < 0.05, ANOVA) 
ma1 controls; t = 1.6; NS). All blood samples 
were drawn at the same time of the day, and 
assays were run simultaneously on fresh blood 
samples from depressed patients and their 
matched controls. Patients were excluded if they 
met criteria for psychiatric disorders other than 
major depression. Normal controls had no evi- 
dence of psychiatric illness. Both patients and 
controls were physically healthy and free of drugs 
known to affect immune regulation, including 
psychoactive drugs. 
A reduction in NK activity may represent an 
important feature of immunoregulation in pa- 
tients with depressive illness. It should, how- 
ever, be noted that this finding is not universally 
seen in patients with major depression. In the 
present study, only 7 of the 12 patients under 
investigation had significantly lower NK activ- 
ity (by paired t-test analysis) than their matched 
controls. The other 5 patients did not differ sig- 
nificantly from their matched controls. In no 
instance did any depressed patient show a sig- 
nificantly higher NK activity than his/her matched 
control. Clinical and neuroendocrine factors that 
distinguish depressed patients with impaired NK 
activity from those with normal NK activity are 
presently under investigation. More work is 
needed to clarify the relation among clinical, 
neuroendocrine, and immune phenomena in pa- 
tients with depressive illness. 
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Ventricle-to-Brain Ratio in Schizophrenia: 
A Controlled Follow-up Study 
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Introduction 
The presence of enlarged lateral cerebral ven- 
tricles on computed tomography (CT) scans of 
a subset of schizophrenic patients has been re- 
ported by several authors (for a review, see 
Shelton and Weinberger 1986). This enlarge- 
ment is commonly believed to predate the onset 
of illness and to be nonprogressive: in fact, most 
studies found no correlation between lateral ven- 
tricle size and duration of illness, and ventricular 
enlargement was also observed in young pa- 
tients with schizophreniform disorder (Wein- 
berger et al. 1982). Nevertheless, controversy 
on this topic persists. It has been argued (Woods 
and Wolf 1983) that the relationship between 
ventricle size and duration of illness was missed 
in some investigations as a consequence of the 
homogeneity of the patient sample with respect 
to the duration itself. Indeed, some studies ex- 
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amining patient samples that were highly het- 
erogeneous with respect to duration of illness 
reported a significant correlation between such 
a variable and the ventricle-to-brain ratio (Kem- 
ali et al. 1987). 
The question of whether the enlargement of 
lateral ventricles in schizophrenia antedates the 
onset of illness or occurs during its course can 
be clarified only by longitudinal studies. How- 
ever, only three investigations of this type have 
been published until now (Nasrallah et al. 1986; 
Illowsky et al. 1988; Vita et A. 1988). of which 
the first was affected by important methodolog- 
ical problems (follow-up only of patients who 
continued to attend the unit as outpatients, use 
of different CT scanners at baseline and at fol- 
low-up), and none included a control popula- 
tion. This is the reason why the present con- 
trolled follow-up study was carried out. 
Methods 
In a previous study (Kemali et al. 1987). we 
performed CT scan in 50 patients with a DSM- 
III diagnosis of schizophrenic disorder and no 
history of alcoholism and drug abuse, who had 
